Cancer Research Technology
Log in Register
Menu

Anti-BZLF1 [BZ1]

Info

Applications IHC
Antigen/Gene or Protein Targets BZLF1
Reactivity Virus
Relevance The Epstein–Barr virus is an oncogenic human gamma-herpesvirus that predominantly establishes latent infection in B lymphocytes. Maintenance of virus latency or execution of reactivation is controlled by the expression of BZLF1, a viral immediate-early gene product, tightly controlled at the transcriptional level. The BZLF1 protein is a transcriptional activator that shares structural similarities to basic leucine zipper (b-Zip) family transcriptional factors and BZLF1 expression alone can trigger the entire Epstein-Barr virus reactivation cascade.
Host Mouse
Subclass IgG
Research Area Cell Cycle, Cell Signaling & Signal Transduction, Epigenetics & Nuclear Signalling, Virology

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Packham et al. 1990. J Virol. 64(5):2110-6. PMID: 2157874.


Add a reference

References: 1 entry

Packham et al. 1990. J Virol. 64(5):2110-6. PMID: 2157874.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor